SPY334.04+1.93 0.58%
DIA273.64+1.64 0.60%
IXIC11,101.61+103.22 0.94%

Gilead Sciences Q2 Adj. EPS $1.11 Misses $1.45 Estimate, Sales $5.10B Miss $5.31B Estimate

Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $1.11 per share which missed the analyst consensus estimate of $1.45 by 23.45 percent. This is a 39.01 percent decrease over earnings of $1.82 per share from

Benzinga · -
Gilead Sciences (NASDAQ: GILD) reported quarterly earnings of $1.11 per share which missed the analyst consensus estimate of $1.45 by 23.45 percent. This is a 39.01 percent decrease over earnings of $1.82 per share from the same period last year. The company reported quarterly sales of $5.10 billion which missed the analyst consensus estimate of $5.31 billion by 3.95 percent. This is a 10.29 percent decrease over sales of $5.68 billion the same period last year.